O Huber-Bruning

1.3k total citations
29 papers, 1.0k citations indexed

About

O Huber-Bruning is a scholar working on Rheumatology, Cell Biology and Immunology and Allergy. According to data from OpenAlex, O Huber-Bruning has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 9 papers in Cell Biology and 7 papers in Immunology and Allergy. Recurrent topics in O Huber-Bruning's work include Osteoarthritis Treatment and Mechanisms (15 papers), Rheumatoid Arthritis Research and Therapies (12 papers) and Proteoglycans and glycosaminoglycans research (9 papers). O Huber-Bruning is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (15 papers), Rheumatoid Arthritis Research and Therapies (12 papers) and Proteoglycans and glycosaminoglycans research (9 papers). O Huber-Bruning collaborates with scholars based in Netherlands and Germany. O Huber-Bruning's co-authors include J. W. J. Bijlsma, Berry Wilbrink, Jocelyn Roy, J. W. J. Bijlsma, J. J. Nietfeld, Willem Den Otter, F.P.J.G. Lafeber, Jan P. Vandenbroucke, A. Cats and Johannes J. Rasker and has published in prestigious journals such as The Lancet, Annals of the Rheumatic Diseases and The Journal of Pathology.

In The Last Decade

O Huber-Bruning

29 papers receiving 932 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O Huber-Bruning Netherlands 18 690 176 132 125 116 29 1.0k
H. G. Faßbender Germany 16 526 0.8× 119 0.7× 165 1.3× 45 0.4× 39 0.3× 39 917
S. Larsson Sweden 21 806 1.2× 548 3.1× 98 0.7× 204 1.6× 70 0.6× 46 1.4k
F A Wollheim Sweden 14 327 0.5× 161 0.9× 68 0.5× 32 0.3× 56 0.5× 22 685
Tadamasa Hanyu Japan 16 284 0.4× 291 1.7× 91 0.7× 45 0.4× 37 0.3× 44 774
Nobunori Takahashi Japan 18 492 0.7× 120 0.7× 206 1.6× 37 0.3× 111 1.0× 108 996
H. Menninger Germany 13 344 0.5× 46 0.3× 156 1.2× 51 0.4× 48 0.4× 38 612
G. Yanni United Kingdom 18 1.0k 1.5× 147 0.8× 660 5.0× 108 0.9× 37 0.3× 26 1.8k
Christian S. Thudium Denmark 21 694 1.0× 176 1.0× 100 0.8× 241 1.9× 31 0.3× 80 1.2k
Manuel Pombo‐Suárez Spain 14 482 0.7× 151 0.9× 69 0.5× 168 1.3× 21 0.2× 28 809
H Bröll Austria 15 352 0.5× 82 0.5× 219 1.7× 33 0.3× 33 0.3× 48 750

Countries citing papers authored by O Huber-Bruning

Since Specialization
Citations

This map shows the geographic impact of O Huber-Bruning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Huber-Bruning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Huber-Bruning more than expected).

Fields of papers citing papers by O Huber-Bruning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O Huber-Bruning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Huber-Bruning. The network helps show where O Huber-Bruning may publish in the future.

Co-authorship network of co-authors of O Huber-Bruning

This figure shows the co-authorship network connecting the top 25 collaborators of O Huber-Bruning. A scholar is included among the top collaborators of O Huber-Bruning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O Huber-Bruning. O Huber-Bruning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roy, Jocelyn, et al.. (1997). Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease. Annals of the Rheumatic Diseases. 56(11). 656–660. 39 indexed citations
2.
Mieremet, R.H.P., et al.. (1994). Changes in proteoglycans of ageing and osteoarthritic human articular cartilage: An electron microscopic study with polyethyleneimine. The Anatomical Record. 240(2). 208–216. 17 indexed citations
3.
Nietfeld, J. J., et al.. (1994). Cytokines and proteoglycans. Birkhäuser Basel eBooks. 70. 215–242. 20 indexed citations
4.
Lafeber, F.P.J.G., et al.. (1993). OSTEOARTHRITIC HUMAN CARTILAGE IS MORE SENSITIVE TO TRANSFORMING GROWTH FACTOR   THAN IS NORMAL CARTILAGE. Lara D. Veeken. 32(4). 281–286. 57 indexed citations
5.
Lafeber, F.P., et al.. (1993). Articular cartilage explant culture; an appropriate in vitro system to compare osteoarthritic and normal human cartilage. Connective Tissue Research. 29(4). 287–299. 70 indexed citations
6.
Lafeber, F.P.J.G., et al.. (1992). INTERMITTENT HYDROSTATIC COMPRESSIVE FORCE STIMULATES EXCLUSIVELY THE PROTEOGLYCAN SYNTHESIS OF OSTEOARTHRITIC HUMAN CARTILAGE. Lara D. Veeken. 31(7). 437–442. 64 indexed citations
7.
Wilbrink, Berry, et al.. (1992). Influence of rheumatoid synovial fluid and cells on proteoglycans in human cartilage explants. Modulation by piroxicam. Clinical Rheumatology. 11(1). 86–91. 1 indexed citations
8.
Wilbrink, Berry, et al.. (1991). In vitro influence of ketoprofen on the proteoglycan metabolism of human normal and osteoarthritis cartilage. Inflammation Research. 32(3-4). 154–159. 8 indexed citations
9.
Wilbrink, Berry, J. J. Nietfeld, Willem Den Otter, et al.. (1991). ROLE OF TNFα, IN RELATION TO IL-1 AND IL-6 IN THE PROTEOGLYCAN TURNOVER OF HUMAN ARTICULAR CARTILAGE. Lara D. Veeken. 30(4). 265–271. 44 indexed citations
10.
Huber-Bruning, O, et al.. (1991). Relation between patients' own health assessment and clinical and laboratory findings in rheumatoid arthritis.. PubMed. 18(5). 650–3. 34 indexed citations
11.
Nietfeld, J. J., Berry Wilbrink, Maarten Helle, et al.. (1990). Interleukin‐1‐induced interleukin‐6 is required for the inhibition of proteoglycan synthesis by interleukin‐1 in human articular cartilage. Arthritis & Rheumatism. 33(11). 1695–1701. 110 indexed citations
12.
Nietfeld, J. J., Berry Wilbrink, Willem Den Otter, J. Huber, & O Huber-Bruning. (1990). The effect of human interleukin 1 on proteoglycan metabolism in human and porcine cartilage explants.. PubMed. 17(6). 818–26. 55 indexed citations
13.
Huber-Bruning, O, et al.. (1989). Potential Influences of Ketoprofen on Human Healthy And Osteoarthritic Cartilage In Vitro. Scandinavian Journal of Rheumatology. 18(sup83). 29–32. 7 indexed citations
14.
Bijlsma, J. W. J., S. A. Duursma, Ricardo J. Bosch, J. A. Raymakers, & O Huber-Bruning. (1988). ACUTE CHANGES IN CALCIUM AND BONE METABOLISM DURING METHYLPREDNISOLONE PULSE THERAPY IN RHEUMATOID ARTHRITIS. Lara D. Veeken. 27(3). 215–219. 19 indexed citations
15.
Huber-Bruning, O, et al.. (1987). Differential responses of old human cartilage explants to synovial- and mononuclear-cell factors. Rheumatology International. 7(5). 223–229. 3 indexed citations
16.
Vandenbroucke, Jan P., H. A. Valkenburg, J. Boersma, et al.. (1987). Changing pattern of drug use in relation to disease duration of rheumatoid arthritis.. PubMed. 14(3). 476–8. 3 indexed citations
17.
Bijlsma, J. W. J., O Huber-Bruning, & J. H. H. Thijssen. (1987). Effect of oestrogen treatment on clinical and laboratory manifestations of rheumatoid arthritis.. Annals of the Rheumatic Diseases. 46(10). 777–779. 50 indexed citations
18.
Vandenbroucke, Jan P., Rudolf Kaaks, Hans A. Valkenburg, et al.. (1987). Frequency of infections among rheumatoid arthritis patients, before and after disease onset. Arthritis & Rheumatism. 30(7). 810–813. 35 indexed citations
19.
Dekker, A. W., et al.. (1987). Acquired sideroblastic anaemia after aplastic anaemia caused by D-penicillamine therapy for rheumatoid arthritis.. Annals of the Rheumatic Diseases. 46(2). 156–158. 5 indexed citations
20.
Huber-Bruning, O, et al.. (1986). Contrasting in vitro effects of retinol and mononuclear cell factor on young and old human cartilage. The Journal of Pathology. 150(1). 21–27. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. G. Faßbender Breakdown of academic impact, for papers by S. Larsson Breakdown of academic impact, for papers by F A Wollheim Breakdown of academic impact, for papers by Tadamasa Hanyu Breakdown of academic impact, for papers by Nobunori Takahashi Breakdown of academic impact, for papers by H. Menninger Breakdown of academic impact, for papers by G. Yanni Breakdown of academic impact, for papers by Christian S. Thudium Breakdown of academic impact, for papers by Manuel Pombo‐Suárez Breakdown of academic impact, for papers by H Bröll
Rankless by CCL
2026